{"filings":[{"id":1332996,"accession_number":"0001803599-26-000133","cik":1803599,"company_name":"Concentrix Corp","ticker":"CNXC","form_type":"8-K","filed_at":"2026-06-29T20:02:54+00:00","items":["2.02","9.01"],"status":"ready","headline":"Concentrix Q2 revenue $2.46B (+1.9% YoY); GAAP EPS $0.86, non-GAAP EPS $2.63, record cash flow","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $2,462.5M (+1.9% YoY as reported; +0.6% constant currency).","GAAP operating income $95.4M (3.9% margin) vs $148.3M (6.1%) a year ago; non-GAAP op income $292.0M (11.9% margin) vs $303.7M.","GAAP diluted EPS $0.86 vs $0.63; non-GAAP diluted EPS $2.63 vs $2.70.","Record Q2 cash from ops $257.9M; adjusted free cash flow $242.3M.","Board declared $0.36 quarterly dividend payable Aug 4, 2026; no share repurchases in quarter; $396.6M repurchase authorization remains."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1614797733.632,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":95580,"accession_number":"0001803599-26-000126","cik":1803599,"company_name":"Concentrix Corp","ticker":"CNXC","form_type":"8-K","filed_at":"2026-05-01T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Director Bilge Ogut resigns after GBL reduces Concentrix stake below nomination threshold","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Bilge Ogut resigned from Concentrix Board effective April 29, 2026.","Resignation triggered by GBL's beneficial ownership falling below 50% of shares issued in Webhelp acquisition.","GBL entered a transaction on April 29, 2026 that reduced its stake below the Board Nomination Threshold.","GBL's nomination right was under the March 29, 2023 Investor Rights Agreement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":1614797733.632,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":108746,"accession_number":"0001803599-26-000092","cik":1803599,"company_name":"Concentrix Corp","ticker":"CNXC","form_type":"8-K","filed_at":"2026-03-27T23:59:59+00:00","items":["5.02","5.07","9.01"],"status":"ready","headline":"Concentrix stockholders approve 3.7M share increase to 2020 equity plan","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Amendment to 2020 Stock Incentive Plan adds 3,700,000 shares, approved at March 25, 2026 Annual Meeting.","Total shares available for issuance under Plan increased to 4,469,067.","Stockholders elected nine directors, ratified Ernst & Young as auditor, and approved say-on-pay."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":1614797733.632,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":108745,"accession_number":"0001803599-26-000084","cik":1803599,"company_name":"Concentrix Corp","ticker":"CNXC","form_type":"8-K","filed_at":"2026-03-24T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Concentrix Q1 revenue up 5.4% but GAAP EPS drops 68% to $0.33, margins shrink","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $2,500.4M (+5.4% YoY); operating income $118.6M (-29.8%); GAAP EPS $0.33 (-68.3%).","Non-GAAP operating income $295.0M (-8.2% YoY); Non-GAAP EPS $2.61 (-6.5%).","Adjusted EBITDA $348.2M (13.9% margin, -190bps YoY); cash used in ops $83.2M.","Declared $0.36 quarterly dividend payable May 5; repurchased 1M shares for $42M in Q1."],"consensus_eps_estimate":null,"consensus_eps_actual":0.33,"consensus_revenue_estimate":null,"consensus_revenue_actual":2500391000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1614797733.632,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":108744,"accession_number":"0001803599-26-000080","cik":1803599,"company_name":"Concentrix Corp","ticker":"CNXC","form_type":"8-K","filed_at":"2026-03-23T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Concentrix expands AR securitization facility to $750M, extends to March 2028","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Commitment increased from $700M to $750M under receivables securitization facility.","Termination date extended from Jan 14, 2027 to March 20, 2028.","Sixth Amendment dated March 20, 2026; PNC Bank remains administrative agent.","Borrower is subsidiary Concentrix Receivables, Inc.; Concentrix acts as servicer."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":1614797733.632,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":108743,"accession_number":"0001803599-26-000074","cik":1803599,"company_name":"Concentrix Corp","ticker":"CNXC","form_type":"8-K","filed_at":"2026-02-24T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Concentrix issues $600M 6.5% senior notes due 2029, redeems $600M of 6.65% notes due 2026","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Issued $600M aggregate principal of 6.500% Senior Notes due March 1, 2029 in a registered public offering.","Net proceeds used with other funds to redeem $600M of its 6.650% Senior Notes maturing August 2, 2026.","Interest on the new notes payable semi-annually on March 1 and September 1, beginning September 1, 2026.","Interest rate subject to adjustment upon rating changes by Moody's, S&P or Fitch.","Notes are redeemable at Concentrix's option, with a par call date of February 1, 2029."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":1614797733.632,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":108742,"accession_number":"0001803599-26-000068","cik":1803599,"company_name":"Concentrix Corp","ticker":"CNXC","form_type":"8-K","filed_at":"2026-02-13T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Concentrix prices $600M of 6.500% senior notes due 2029; will redeem $600M of existing 6.650% notes","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Issued $600M principal of 6.500% Senior Notes due 2029; priced Feb 12, 2026.","Proceeds to redeem $600M of 6.650% Senior Notes due Aug 2, 2026; closing expected Feb 24.","Existing 2026 notes had $800M outstanding; after redemption $200M will remain.","Offering led by BofA Securities and J.P. Morgan as joint book-running managers.","New notes extend maturity from 2026 to 2029 with a slightly lower coupon."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":1614797733.632,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":108741,"accession_number":"0001803599-26-000003","cik":1803599,"company_name":"Concentrix Corp","ticker":"CNXC","form_type":"8-K","filed_at":"2026-01-13T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Concentrix reports Q4 GAAP loss of $23.85/sh on $1.5B goodwill impairment; FY rev +2.2%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $2,552.9M (+4.3% YoY); FY revenue $9,825.8M (+2.2% YoY).","Q4 GAAP operating loss $1,382.4M includes $1,523.3M non-cash goodwill impairment; FY op loss $918.2M.","Non-GAAP diluted EPS Q4 $2.95 (vs $3.26); FY $11.22 (vs $11.42); margins declined 90-170 bps.","FY adjusted free cash flow $626.4M; cash from operations $807.0M; net debt reduced $184M.","FY returned $258M to shareholders; Q4 dividend $0.36 payable Feb 10, 2026; share repurchase auth $438.6M."],"consensus_eps_estimate":null,"consensus_eps_actual":-20.36,"consensus_revenue_estimate":null,"consensus_revenue_actual":9825771000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":1614797733.632,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":141915,"accession_number":"0001803599-25-000143","cik":1803599,"company_name":"Concentrix Corp","ticker":"CNXC","form_type":"8-K","filed_at":"2025-09-25T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Concentrix Q3 revenue above guidance; raises full-year growth outlook, increases dividend","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $2,483M (+4.0% YoY), above guidance; constant-currency growth 2.6%.","Non-GAAP diluted EPS $2.78 vs $2.87 YoY; GAAP EPS $1.34 vs $0.25.","Adjusted EBITDA $359M (14.5% margin), down from $388M (16.3%) YoY.","Dividend raised to $0.36/share (+8%), payable Nov 4 to holders of record Oct 24.","Repurchased 800k shares for $42.2M in Q3; $495.1M remaining authorization."],"consensus_eps_estimate":null,"consensus_eps_actual":3.01,"consensus_revenue_estimate":null,"consensus_revenue_actual":7272846000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1614797733.632,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":159845,"accession_number":"0001803599-25-000127","cik":1803599,"company_name":"Concentrix Corp","ticker":"CNXC","form_type":"8-K","filed_at":"2025-06-26T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Concentrix Q2 rev $2.417B (+1.5% YoY) beats guidance; raises FY outlook; EPS $0.63 GAAP, $2.70 non-GAAP","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $2,417M (+1.5% YoY) beat guidance; full-year growth outlook raised.","GAAP diluted EPS $0.63 vs $0.98 YoY; non-GAAP diluted EPS $2.70 vs $2.69 (+0.4%).","Adjusted EBITDA $357M (14.8% margin) down 5.9% YoY on temporary program pauses.","Generated $200M adjusted free cash flow in Q2; on track for $625-650M full year.","Board declared $0.33275/sh dividend payable Aug 5, 2025; $45M in share repurchases in Q2."],"consensus_eps_estimate":2.803,"consensus_eps_actual":1.68,"consensus_revenue_estimate":null,"consensus_revenue_actual":4789593000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl+finnhub","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1614797733.632,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":159844,"accession_number":"0001803599-25-000123","cik":1803599,"company_name":"Concentrix Corp","ticker":"CNXC","form_type":"8-K","filed_at":"2025-06-05T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Director Olivier Duha resigns from Concentrix board for personal reasons","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Olivier Duha notified the Board of his resignation effective June 3, 2025.","Resignation was for personal reasons, not due to any disagreement with the Company.","Mr. Duha also stepped down from all board committees."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":1614797733.632,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":159843,"accession_number":"0001803599-25-000111","cik":1803599,"company_name":"Concentrix Corp","ticker":"CNXC","form_type":"8-K","filed_at":"2025-04-11T23:59:59+00:00","items":["1.01","2.03","8.01","9.01"],"status":"ready","headline":"Concentrix amends credit facility: adds $1.5B delayed draw, extends maturities, refinances $750M term loan","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["New unsecured facilities: $750M 3-year term loan, $250M 3-year delayed draw, $500M 5-year delayed draw, and $1.1B revolver; $750M converted to Continued Term Loan maturing Dec 2026.","Delayed draw proceeds (up to $750M) to repay €700M promissory note from Webhelp deal; must be drawn by Sep 30, 2025.","Covenants: max leverage ratio 3.75x (4.25x post qualified acquisitions), min interest coverage 3.00x.","Bank of America replaces JPMorgan as administrative agent under restated credit agreement.","Maturities: New term & 3-year DD Sep 30, 2028; 5-year DD & revolver Apr 11, 2030 (revolver extendable)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1614797733.632,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":178211,"accession_number":"0001803599-25-000100","cik":1803599,"company_name":"Concentrix Corp","ticker":"CNXC","form_type":"8-K","filed_at":"2025-03-31T23:59:59+00:00","items":["5.03","5.07","9.01"],"status":"ready","headline":"Concentrix stockholders approve charter amendment enabling special meetings with 25% threshold","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Charter amendment approved to permit stockholders owning at least 25% of common stock to call special meetings; effective March 25, 2025.","Bylaws amended to require a net long position for ≥1 year, continuous ownership, and restrictions on meeting timing.","Management charter amendment passed (46.5M for, 389K against); shareholder special meeting proposal defeated (20.9M for, 32.7M against).","All 10 director nominees elected; advisory say-on-pay passed (52.4M for, 1.1M against); Ernst & Young ratified as auditor."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":1614797733.632,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":178210,"accession_number":"0001803599-25-000080","cik":1803599,"company_name":"Concentrix Corp","ticker":"CNXC","form_type":"8-K","filed_at":"2025-03-26T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Concentrix beats Q1 guidance; revenue $2.37B, non-GAAP EPS $2.79","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $2,372M (-1.3% YoY); constant-currency growth +1.3%.","GAAP diluted EPS $1.04; non-GAAP diluted EPS $2.79, up 8.6% YoY.","Adjusted EBITDA $374M (15.8% margin); cash from ops $1.4M.","Declares quarterly dividend $0.33275/share, payable May 6, 2025.","Reaffirms FY2025 adj. free cash flow guidance $625-650M; expects >$240M shareholder returns."],"consensus_eps_estimate":null,"consensus_eps_actual":1.04,"consensus_revenue_estimate":null,"consensus_revenue_actual":2372222000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1614797733.632,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":178209,"accession_number":"0001803599-25-000014","cik":1803599,"company_name":"Concentrix Corp","ticker":"CNXC","form_type":"8-K","filed_at":"2025-01-21T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Concentrix expands receivables securitization to $700M, extends to Jan 2027","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Facility commitment increased from $600M to $700M.","Termination date extended from April 24, 2026 to January 14, 2027.","Amendment effective January 14, 2025; no other material changes to terms.","Borrowing capacity supports working capital; secured by trade receivables."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":1614797733.632,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":178208,"accession_number":"0001803599-25-000011","cik":1803599,"company_name":"Concentrix Corp","ticker":"CNXC","form_type":"8-K","filed_at":"2025-01-15T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Concentrix Q4 rev $2.45B (+9.7% YoY); GAAP EPS $1.72; buyback auth raised to $600M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $2,448M (+9.7% YoY); FY2024 revenue $9,619M (+35.2% YoY, includes acquisitions).","GAAP operating margin 5.9% (down 220bps); Non-GAAP op margin 14.2% (down 110bps) on GenAI investments.","GAAP diluted EPS $1.72 vs $1.09; Non-GAAP diluted EPS $3.26 vs $3.36.","Adjusted EBITDA Q4 $402.9M (16.5% margin); FY adjusted free cash flow $474.5M.","Quarterly dividend $0.33275/sh payable Feb 11; share repurchase authorization increased to $600M."],"consensus_eps_estimate":null,"consensus_eps_actual":3.71,"consensus_revenue_estimate":null,"consensus_revenue_actual":9618900000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":1614797733.632,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":178207,"accession_number":"0001803599-25-000005","cik":1803599,"company_name":"Concentrix Corp","ticker":"CNXC","form_type":"8-K","filed_at":"2025-01-10T23:59:59+00:00","items":["5.03","9.01"],"status":"ready","headline":"Concentrix amends bylaws to remove supermajority vote requirement for bylaw amendments","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Board adopted Amendment No. 2 to Bylaws, effective January 9, 2025.","Super-majority provision (66-2/3%) replaced with simple majority for adopting, amending, or repealing Bylaws.","Change applies to voting power of outstanding shares of capital stock."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":1614797733.632,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":194870,"accession_number":"0001803599-24-000187","cik":1803599,"company_name":"Concentrix Corp","ticker":"CNXC","form_type":"8-K","filed_at":"2024-10-30T23:59:59+00:00","items":["4.01","9.01"],"status":"ready","headline":"Concentrix appoints EY as independent auditor for FY2025, replacing KPMG","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Audit Committee selected EY on Oct 25, 2024, subject to standard client acceptance and engagement letter.","KPMG will be dismissed after completing FY2024 audit; no disagreements or reportable events occurred.","KPMG's audit reports for FY2022 and FY2023 were unqualified with no adverse opinions.","No prior consultations with EY on accounting principles or audit opinion matters."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":1614797733.632,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":194869,"accession_number":"0001803599-24-000179","cik":1803599,"company_name":"Concentrix Corp","ticker":"CNXC","form_type":"8-K","filed_at":"2024-10-29T23:59:59+00:00","items":["5.02","5.07","9.01"],"status":"ready","headline":"Concentrix shareholders approve charter amendment and 3M share increase for 2020 Plan","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Stockholders approved Charter Amendment removing 66-2/3% supermajority voting standard (56,024,770 for, 116,157 against).","Amended 2020 Stock Incentive Plan approved, increasing authorized shares by 3,000,000 and removing evergreen provision.","Adjournment Proposal passed with 40,744,905 votes for.","Changes effective following special meeting held on October 28, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":1614797733.632,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":211159,"accession_number":"0001803599-24-000150","cik":1803599,"company_name":"Concentrix Corp","ticker":"CNXC","form_type":"8-K","filed_at":"2024-09-25T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Concentrix Q3 revenue $2.39B beats guidance; raises dividend 10%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $2,387.4M, +46.2% YoY; pro forma const cur rev growth 2.6%. GAAP EPS $0.25, Non-GAAP EPS $2.87 +4% YoY.","Q3 GAAP operating income $153.2M, down 5.6% on higher amortization and Webhelp integration costs.","Non-GAAP op margin 13.9% vs 14.1% prior year; Adj EBITDA $388.1M (16.3% margin).","Board raised quarterly dividend to $0.33275/share from $0.3025, a 10% increase; paid $39.1M on 0.6M share repurchases.","Launched iX Hello, GenAI product for productivity/engagement; no specific revenue guidance provided for Q4 or FY24."],"consensus_eps_estimate":null,"consensus_eps_actual":2.0,"consensus_revenue_estimate":null,"consensus_revenue_actual":7170876000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1614797733.632,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":229701,"accession_number":"0001803599-24-000125","cik":1803599,"company_name":"Concentrix Corp","ticker":"CNXC","form_type":"8-K","filed_at":"2024-06-26T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Concentrix Q2 revenue $2.38B (+47% YoY), beats expectations; raises FY2024 revenue guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $2,380.7M, up 47.4% YoY; GAAP EPS $0.98 (down 35%), non-GAAP EPS $2.69 (up 2.3%).","Adjusted free cash flow $201.9M; operating cash flow $238.3M; returned $60M via buybacks ($40.3M) and dividends.","Board declared $0.3025/share dividend payable Aug 6, 2024; share repurchase authorization $227.2M remains.","Webhelp integration on track; raised full-year 2024 revenue guidance and reaffirmed adjusted free cash flow outlook.","Non-GAAP operating margin 13.5% vs 13.7% prior year; adjusted EBITDA margin 15.9% vs 16.0%."],"consensus_eps_estimate":null,"consensus_eps_actual":1.74,"consensus_revenue_estimate":null,"consensus_revenue_actual":4783464000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":1614797733.632,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":229700,"accession_number":"0001803599-24-000117","cik":1803599,"company_name":"Concentrix Corp","ticker":"CNXC","form_type":"8-K","filed_at":"2024-04-26T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Concentrix increases receivables securitization facility to $600M and extends to April 2026","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Commitment raised from $500M to $600M; termination extended from July 2024 to April 2026.","Interest rate margins: commercial paper rate +0.80%, SOFR +0.90% with 0.10% SOFR adjustment.","New conduit lenders GTA Funding LLC and Cabot Trail Funding LLC added to facility.","All conditions precedent satisfied; Performance Guaranty reaffirmed and remains in effect."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":1614797733.632,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":248214,"accession_number":"0001803599-24-000101","cik":1803599,"company_name":"Concentrix Corp","ticker":"CNXC","form_type":"8-K","filed_at":"2024-03-26T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Concentrix Q1 revenue $2.4B (+46.8% YoY), GAAP EPS $0.76 (-54.8%), non-GAAP EPS $2.57 (-0.8%)","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $2,402.7M, up 46.8% YoY; proforma constant currency growth of 2.8%.","GAAP diluted EPS $0.76 (down 54.8%), non-GAAP diluted EPS $2.57 (down 0.8% YoY).","Adjusted EBITDA $384.3M (16.0% margin) vs $255.8M (15.6% margin) a year ago.","Company confirms full-year FY2024 outlook; commits to $100M share repurchases over remaining 3 quarters.","Board declares $0.3025 per share quarterly dividend payable May 7, 2024, to holders of record Apr 26."],"consensus_eps_estimate":null,"consensus_eps_actual":0.76,"consensus_revenue_estimate":null,"consensus_revenue_actual":2402748000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1614797733.632,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":248213,"accession_number":"0001803599-24-000069","cik":1803599,"company_name":"Concentrix Corp","ticker":"CNXC","form_type":"8-K","filed_at":"2024-03-22T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Concentrix shareholders elect all ten director nominees, ratify KPMG, approve say-on-pay","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All ten director nominees elected with votes ranging from 52.0M to 56.7M; Dennis Polk received most withhold votes (5.2M).","Ratification of KPMG LLP as auditor for FY2024 passed with 58.9M for, 33,400 against, 73,705 abstain.","Advisory vote on named executive officer compensation approved with 53.5M for, 3.7M against, 85,250 abstain (1.8M broker non-votes)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"market_cap_usd":1614797733.632,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":248212,"accession_number":"0001803599-24-000064","cik":1803599,"company_name":"Concentrix Corp","ticker":"CNXC","form_type":"8-K","filed_at":"2024-03-22T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Concentrix files Webhelp H1 2023 financials; revenue €1,320M (+12% YoY)","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Webhelp revenue for H1 2023: €1,320.4M (up 12.1% YoY); Q2 2023 revenue €642.1M (up 9.1%).","Goodwill on Webhelp balance sheet at June 30, 2023: €2,118.7M; no impairment recognized.","Acquisition consideration includes €500M cash, €700M notes, 14.86M CNXC shares, plus 0.75M contingent shares."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":1614797733.632,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":248211,"accession_number":"0001803599-24-000009","cik":1803599,"company_name":"Concentrix Corp","ticker":"CNXC","form_type":"8-K","filed_at":"2024-01-24T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Concentrix Q4 revenue $2.23B (+36% YoY); GAAP EPS $1.09, non-GAAP EPS $3.36","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $2,230.8M (+36% YoY); GAAP EPS $1.09 (down 46% YoY).","Non-GAAP EPS $3.36 (+20% YoY); Adjusted EBITDA margin 17.8% (up 40 bps).","Full year FY2023 revenue $7,114.7M (+12.5%); GAAP EPS $5.70 vs $8.28, non-GAAP EPS $11.45 vs $11.19.","Quarterly dividend declared $0.3025/share, payable Feb 15 to holders of record Feb 5.","Management cites strong results and smooth Webhelp integration contributing to revenue and profit."],"consensus_eps_estimate":null,"consensus_eps_actual":5.7,"consensus_revenue_estimate":null,"consensus_revenue_actual":7114706000.0,"consensus_period":"2023-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1614797733.632,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":248210,"accession_number":"0001803599-24-000004","cik":1803599,"company_name":"Concentrix Corp","ticker":"CNXC","form_type":"8-K","filed_at":"2024-01-05T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Concentrix appoints Craig Gibson as EVP Global Sales and Account Management effective Jan 4, 2024","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Gibson joined from Webhelp, where he was Chief Growth Officer.","Rick Rosso transitions to non-executive leadership role before retirement.","Appointment part of Concentrix's executive officer succession planning."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":1614797733.632,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":282898,"accession_number":"0001803599-23-000191","cik":1803599,"company_name":"Concentrix Corp","ticker":"CNXC","form_type":"8-K","filed_at":"2023-09-27T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Concentrix Q3 revenue up 3.4% to $1.63B; raises dividend 10% to $0.3025/share","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP EPS $1.49 (down 27% YoY); non-GAAP EPS $2.71 (down 8.1%).","Free cash flow $167.5M, up 32% YoY; operating cash flow $211.4M.","Board declares Q4 dividend of $0.3025/share (10% increase), payable Nov 7.","Repurchased 0.3M shares at avg $84.35; remaining authorization $312.1M.","Combination with Webhelp complete; vendor consolidation trend cited as growth driver."],"consensus_eps_estimate":null,"consensus_eps_actual":4.67,"consensus_revenue_estimate":null,"consensus_revenue_actual":4883944000.0,"consensus_period":"2023-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1614797733.632,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":282897,"accession_number":"0001803599-23-000187","cik":1803599,"company_name":"Concentrix Corp","ticker":"CNXC","form_type":"8-K","filed_at":"2023-09-25T23:59:59+00:00","items":["1.01","2.01","2.03","3.02","5.02","7.01","8.01","9.01"],"status":"ready","headline":"Concentrix closes $4B Webhelp acquisition, issues ~14.9M shares and €700M seller note","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Transaction valued at ~$4B including net debt; Concentrix paid €488.7M cash, ~14.9M shares, plus up to 750K earnout shares.","Combined co. operates as Concentrix + Webhelp; pre-deal Concentrix shareholders hold 77.6%, Webhelp sellers hold 22.4%.","Olivier Duha (Webhelp co-founder/former CEO) and Nicolas Gheysens (GBL partner) appointed to Board; Duha named Vice Chair.","Issued €700M seller promissory note at 2% interest due Sept 2025; funded deal with $2.15B senior notes and ~$294.7M term loan.","Repaid ~€1.8B of Webhelp existing debt using proceeds from financing and cash on hand."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":1614797733.632,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":282896,"accession_number":"0001803599-23-000184","cik":1803599,"company_name":"Concentrix Corp","ticker":"CNXC","form_type":"8-K","filed_at":"2023-09-15T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Concentrix secures all regulatory approvals for Webhelp combination; close expected Sept 25","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["All required regulatory approvals obtained for pending Webhelp combination; closing on or about September 25, 2023.","Combination to create leading global CX solutions provider with broad digital services and technology at scale.","Fiscal Q3 2023 results to be released Sept 27 after market close; conference call at 5:00 PM ET."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":1614797733.632,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":282895,"accession_number":"0001803599-23-000182","cik":1803599,"company_name":"Concentrix Corp","ticker":"CNXC","form_type":"8-K","filed_at":"2023-08-04T23:59:59+00:00","items":["5.07","8.01","9.01"],"status":"ready","headline":"Concentrix shareholders approve Webhelp combination stock issuance","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Shareholders approved issuance of 15,611,885 shares for Webhelp combination; 92% voted in favor.","Over 89% of outstanding shares were present or represented by proxy at August 4 special meeting.","Transaction remains subject to customary closing conditions including regulatory approvals.","Combination expected to close in Q4 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":1614797733.632,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":282894,"accession_number":"0001803599-23-000177","cik":1803599,"company_name":"Concentrix Corp","ticker":"CNXC","form_type":"8-K","filed_at":"2023-08-02T23:59:59+00:00","items":["1.01","2.03","8.01","9.01"],"status":"ready","headline":"Concentrix issues $2.15B in senior notes to fund Webhelp acquisition, eliminates bridge loan","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Issued $800M 6.650% notes due 2026, $800M 6.600% notes due 2028, and $550M 6.850% notes due 2033.","Net proceeds to fund cash consideration for pending Webhelp acquisition, repay Webhelp debt, and pay fees.","Remaining $2.15B bridge loan commitment from JPMorgan reduced to zero on August 2, 2023.","Notes sold in registered public offering; indenture includes customary covenants and events of default."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1614797733.632,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":282893,"accession_number":"0001803599-23-000165","cik":1803599,"company_name":"Concentrix Corp","ticker":"CNXC","form_type":"8-K","filed_at":"2023-07-20T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Concentrix prices $2.15B senior notes offering to fund Webhelp acquisition","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Priced $800M 6.650% notes due 2026, $800M 6.600% notes due 2028, $550M 6.850% notes due 2033.","Net proceeds to fund cash consideration for pending Webhelp acquisition, repay Webhelp debt, pay fees.","Offering expected to close August 2, 2023, subject to customary conditions.","Notes subject to special mandatory redemption at 101% if acquisition not closed by certain date.","Joint book-runners: J.P. Morgan, BofA, HSBC, MUFG, PNC, Scotia, SMBC, TD, Truist, U.S. Bancorp, Wells Fargo."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1614797733.632,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":282892,"accession_number":"0001803599-23-000159","cik":1803599,"company_name":"Concentrix Corp","ticker":"CNXC","form_type":"8-K","filed_at":"2023-07-17T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Concentrix receives demand letters over Webhelp proxy; amends deal structure with restricted shares","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Seven stockholder demand letters allege proxy omitted material info on transaction; company says demands are without merit.","Amendment to acquisition agreement adds vendor notes for OD Sellers and Jousset, and restricted shares in lieu of earnout shares for certain sellers.","Restricted shares subject to same $170/share price trigger and 7-year period as earnout shares; max 100,000 restricted shares issuable.","GBL Sellers, Jousset, and OD Sellers elect to keep earnout shares; other sellers may choose restricted shares.","Total consideration unchanged: €500M cash, €700M seller's note, 14.86M new shares, and vendor loans."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1614797733.632,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":282891,"accession_number":"0001140361-23-034695","cik":1803599,"company_name":"Concentrix Corp","ticker":"CNXC","form_type":"8-K","filed_at":"2023-07-17T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Concentrix files Webhelp financials for pending acquisition; Q1 2023 revenue €678M, adj. EBITDA €387.9M (U.S. GAAP)","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["FY2022 adj. EBITDA €376.3M (U.S. GAAP); LTM Mar 2023 adj. EBITDA €387.9M ($404.1M).","Q1 2023 revenue €678.3M (+15.1% YoY); net profit €14.7M (down from €20.4M in Q1 2022).","Non-current financial liabilities €1.74B; cash and equivalents €350.5M as of Mar 31, 2023.","Transaction announced Mar 29, 2023; subject to regulatory and Concentrix shareholder approvals.","Top revenue verticals in Q1 2023: e-commerce/retail €162.1M, telecom €104.1M, digital/high-tech €106.7M."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1614797733.632,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":302240,"accession_number":"0001803599-23-000144","cik":1803599,"company_name":"Concentrix Corp","ticker":"CNXC","form_type":"8-K","filed_at":"2023-06-28T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Concentrix Q2 revenue up 3% to $1.61B; GAAP EPS $1.51, non-GAAP EPS $2.69","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $1,614.7M (+3% YoY); operating margin 10.1% vs 10.0% a year ago.","GAAP net income $78.9M (-30% YoY); non-GAAP net income $140.6M (-9% YoY).","Adjusted EBITDA $258.8M (16.0% margin); free cash flow $101.3M in Q2.","Quarterly dividend of $0.275 declared, payable Aug 8, 2023; $339.1M remaining buyback authorization.","Management cites margin expansion and AI progress; notes some client volumes below expectations."],"consensus_eps_estimate":null,"consensus_eps_actual":3.18,"consensus_revenue_estimate":null,"consensus_revenue_actual":3251110000.0,"consensus_period":"2023-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1614797733.632,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":302239,"accession_number":"0001803599-23-000135","cik":1803599,"company_name":"Concentrix Corp","ticker":"CNXC","form_type":"8-K","filed_at":"2023-06-12T23:59:59+00:00","items":["1.01","3.02","9.01"],"status":"ready","headline":"Concentrix (CNXC) signs definitive agreement to acquire Webhelp for €500M cash plus stock and earnout","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Total consideration for Acquired Shares includes €500M cash, Parent common stock issuance, a Sellers' Note, and contingent Earnout Shares.","Closing subject to stockholder approval of Parent Share Issuance (special meeting), antitrust/regulatory clearances, and other customary conditions.","Works councils have been informed and consulted; transaction expected to close in 2023, with a marketing period for debt financing.","Parent Board recommends the stock issuance; MiTac Holdings, a major stockholder, has executed a support agreement to vote in favor.","Post-closing, certain Sellers will receive board representation rights under the Investor Rights Agreement executed on Put Option date."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":1614797733.632,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":302238,"accession_number":"0001803599-23-000107","cik":1803599,"company_name":"Concentrix Corp","ticker":"CNXC","form_type":"8-K","filed_at":"2023-04-26T23:59:59+00:00","items":["1.01","2.03","8.01","9.01"],"status":"ready","headline":"Concentrix amends credit facility to $3.187B for Webhelp combination financing","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Restated Credit Agreement: $1.0425B revolving facility and $2.1447B term loan facility (incl. $294.7M delayed draw).","Maturity December 27, 2026; SOFR loans bear interest at SOFR + 1.125%-2.00% margin plus 0.10% credit spread adjustment.","Financial covenants: leverage ratio ≤ 3.75:1 (4.25:1 post-qualified acquisitions) and interest coverage ratio ≥ 3.00:1.","Bridge commitments reduced: $1.85B Term Loan Amendment Bridge and $1.0B Revolving Amendment Bridge to zero; $2.44B Term Loan Acquisition Bridge reduced by ~$294.7M.","Proceeds from delayed draw term loans will finance a portion of the Webhelp Combination and related fees."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1614797733.632,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":321904,"accession_number":"0001803599-23-000091","cik":1803599,"company_name":"Concentrix Corp","ticker":"CNXC","form_type":"8-K","filed_at":"2023-03-31T23:59:59+00:00","items":["1.01","3.02","8.01","9.01"],"status":"ready","headline":"Concentrix to acquire Webhelp for €1.2B cash/note plus 14.86M shares; $5.29B bridge loan arranged","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Total consideration: €500M cash + €700M seller note (2% interest, 2-year) + 14.86M shares + up to 750K earnout shares.","Bridge loan of $5.29B from JPMorgan to fund cash portion and refinance debt.","Voting agreement with Concentrix shareholders owning 15.3% to support share issuance.","Investor rights agreement grants GBL two board seats initially; lock-up periods up to 18 months.","Transaction expected to close before end of 2023, subject to works council consultations, HSR, and shareholder approval."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.9,"calibrated_materiality_score":0.9,"market_cap_usd":1614797733.632,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":321903,"accession_number":"0001803599-23-000081","cik":1803599,"company_name":"Concentrix Corp","ticker":"CNXC","form_type":"8-K","filed_at":"2023-03-30T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Concentrix to combine with Webhelp in $4.8B deal; creates $9.8B revenue CX leader","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Enterprise value $4.8B; expected close by end of 2023 subject to shareholder and regulatory approvals.","Combined company estimated 2023 revenue of $9.8B, operating in 70+ countries with ~2,000 clients.","Webhelp brings 120,000+ employees in 58 countries; CEO Olivier Duha to become Vice Chairperson.","Transaction expected to be accretive to revenue growth, profitability, and non-GAAP EPS in first year.","Adds 1,000 new brands including 200+ new economy and 25+ Fortune Global 500 clients."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":1614797733.632,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":321902,"accession_number":"0001803599-23-000075","cik":1803599,"company_name":"Concentrix Corp","ticker":"CNXC","form_type":"8-K","filed_at":"2023-03-29T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Concentrix to acquire Webhelp for ~$4.8B, creating combined CX leader with ~$9.8B pro forma revenue","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Transaction valued at ~$4.8B including net debt; Webhelp shareholders receive 14.9M CNXC shares, €500M cash, and €700M note payable at 2%.","Pro forma 2023 revenue ~$9.8B; Webhelp expected to generate ~$3.0B revenue and ~$500M adjusted EBITDA in 2023.","Cost synergies of $75M in first full year, reaching at least $120M net of investments by third full year.","Accretive to non-GAAP EPS in first full year, with double-digit accretion in second full year; net debt-to-adjusted EBITDA ~3x at close, declining to ~2x within two years.","Chris Caldwell to lead combined company; Olivier Duha to become Vice Chair; transaction expected to close by end of 2023 subject to shareholder and regulatory approvals."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.95,"calibrated_materiality_score":0.95,"market_cap_usd":1614797733.632,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":321901,"accession_number":"0001803599-23-000073","cik":1803599,"company_name":"Concentrix Corp","ticker":"CNXC","form_type":"8-K","filed_at":"2023-03-29T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Concentrix Q1 revenue up 6.5% to $1.64B; GAAP EPS down 19.6% to $1.68","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $1,636.4M, up 6.5% YoY; non-GAAP operating margin expanded 20 bps to 13.3%.","GAAP net income $87.9M ($1.68 diluted EPS) vs $110.3M ($2.09) prior year, down 20.3%.","Adjusted EBITDA $255.8M (15.6% margin) vs $237.9M (15.5% margin) prior year.","Cash from operations $103.9M; free cash flow $64.3M in the quarter.","Declared $0.275 quarterly dividend payable May 9, 2023; repurchased 0.1M shares at avg $140.19."],"consensus_eps_estimate":null,"consensus_eps_actual":1.68,"consensus_revenue_estimate":null,"consensus_revenue_actual":1636404000.0,"consensus_period":"2023-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":1614797733.632,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":321900,"accession_number":"0001803599-23-000050","cik":1803599,"company_name":"Concentrix Corp","ticker":"CNXC","form_type":"8-K","filed_at":"2023-03-27T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Concentrix shareholders elect eight directors, ratify KPMG, approve say-on-pay","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All eight director nominees elected with majority support; highest withhold 2.1M for Dennis Polk.","KPMG ratified as auditor for FY2023 with 47.1M for, 35.9K against.","Advisory say-on-pay approved with 39.5M for, 6.1M against, 46.6K abstain (13.4% against).","Broker non-votes recorded on director election and say-on-pay, none on auditor ratification."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"market_cap_usd":1614797733.632,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":321899,"accession_number":"0001803599-23-000006","cik":1803599,"company_name":"Concentrix Corp","ticker":"CNXC","form_type":"8-K","filed_at":"2023-01-19T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Concentrix Q4 revenue $1.64B (+11.9% YoY); GAAP EPS $2.01, non-GAAP $3.01","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $1,640.7M (+11.9% YoY); FY revenue $6,324.5M (+13.2%).","Q4 GAAP diluted EPS $2.01 (vs $2.35 YoY); non-GAAP diluted EPS $3.01 (vs $2.99).","Q4 adjusted EBITDA $284.8M (17.4% margin vs 16.2% YoY).","Declared $0.275/share dividend payable Feb 10, 2023; repurchased $12.7M shares in Q4.","Management cited softness in consumer electronics, e-commerce, retail; provided FY2023 outlook."],"consensus_eps_estimate":null,"consensus_eps_actual":8.28,"consensus_revenue_estimate":null,"consensus_revenue_actual":6324473000.0,"consensus_period":"2022-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1614797733.632,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":357299,"accession_number":"0001803599-22-000126","cik":1803599,"company_name":"Concentrix Corp","ticker":"CNXC","form_type":"8-K","filed_at":"2022-09-28T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Concentrix Q3 revenue $1.58B (+13.1% YoY); non-GAAP EPS $2.95; dividend raised 10%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $1,579.6M (+13.1% YoY, +7.5% constant currency); non-GAAP operating margin 14.0% (+100 bps).","GAAP diluted EPS $2.04 (down 1.9% YoY); non-GAAP diluted EPS $2.95 (+18.5% YoY).","Adjusted EBITDA $258.4M (16.4% margin, +100 bps YoY); cash from operations $152.6M, free cash flow $126.4M.","Quarterly dividend raised 10% to $0.275/share, payable Nov 8, 2022 to holders of record Oct 28, 2022.","Repurchased 0.4M shares for $50.3M in Q3; remaining authorization $366.8M as of Aug 31, 2022."],"consensus_eps_estimate":null,"consensus_eps_actual":6.28,"consensus_revenue_estimate":null,"consensus_revenue_actual":4683755000.0,"consensus_period":"2022-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1614797733.632,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":357298,"accession_number":"0001803599-22-000116","cik":1803599,"company_name":"Concentrix Corp","ticker":"CNXC","form_type":"8-K","filed_at":"2022-07-20T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Concentrix closes acquisition of ServiceSource to bolster B2B digital sales capabilities","summary_kind":"llm","event_type":"m_and_a","confidence":"medium","bullets":["Acquisition of global B2B digital sales company ServiceSource International completed on July 20, 2022.","Deal expands Concentrix's CX portfolio with complementary sales solutions and global scale.","Concentrix CEO Chris Caldwell cited enhanced ability to address client demands for revenue growth with CX.","ServiceSource COO Mike Naughton highlighted shared vision for customer acquisition and retention."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1614797733.632,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":375905,"accession_number":"0001803599-22-000102","cik":1803599,"company_name":"Concentrix Corp","ticker":"CNXC","form_type":"8-K","filed_at":"2022-06-27T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Concentrix Q2 revenue $1.57B (+14.5% YoY); GAAP EPS $2.14, non-GAAP $2.93","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $1,568.1M (+14.5% YoY); GAAP EPS $2.14 (+36.3%), non-GAAP EPS $2.93 (+23.6%).","Adjusted EBITDA $249.9M, margin 15.9% (+70 bps); operating cash flow $167.5M.","Declared $0.25 quarterly dividend payable Aug 9, 2022 to holders of record July 29, 2022.","Repurchased 0.4M shares for $57.8M in Q2; remaining buyback authorization $417.1M.","CEO cites increased FX headwinds and client shifts offshore, but confident in growth and margins."],"consensus_eps_estimate":null,"consensus_eps_actual":4.23,"consensus_revenue_estimate":null,"consensus_revenue_actual":3104153000.0,"consensus_period":"2022-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1614797733.632,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":375904,"accession_number":"0001803599-22-000092","cik":1803599,"company_name":"Concentrix Corp","ticker":"CNXC","form_type":"8-K","filed_at":"2022-05-09T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Concentrix to acquire ServiceSource for $1.50/share, ~$131M total","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["All-cash deal valued at ~$131M, including ~$20M net cash; $1.50/share price.","Expected year-one contribution: ~$230M revenue and ~$38M adjusted EBITDA.","Implied EV/EBITDA multiple ~3.5x based on expected year-one adjusted EBITDA.","Closing expected in H2 FY2022, subject to ServiceSource shareholder and regulatory approvals.","Edenbrook Capital and Archon Capital, owning ~31% of SREV shares, agreed to vote in favor."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1614797733.632,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":394221,"accession_number":"0001803599-22-000070","cik":1803599,"company_name":"Concentrix Corp","ticker":"CNXC","form_type":"8-K","filed_at":"2022-03-29T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Concentrix Q1 revenue $1.54B, up 13.5% YoY; non-GAAP EPS $2.85, up 24.5%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $1,536.1M (+13.5% YoY); GAAP diluted EPS $2.09 (+23.7%); Non-GAAP diluted EPS $2.85 (+24.5%).","Operating income $147.7M (9.6% margin); Non-GAAP operating margin 13.1%, flat YoY.","Cash from operations $45.0M; Free cash flow $(0.4)M for the quarter.","Declared $0.25 quarterly dividend payable May 10, 2022; remaining buyback authorization $474.9M."],"consensus_eps_estimate":null,"consensus_eps_actual":2.09,"consensus_revenue_estimate":null,"consensus_revenue_actual":1536052000.0,"consensus_period":"2022-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1614797733.632,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":394220,"accession_number":"0001803599-22-000066","cik":1803599,"company_name":"Concentrix Corp","ticker":"CNXC","form_type":"8-K","filed_at":"2022-03-25T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Concentrix stockholders elect all eight director nominees and ratify KPMG","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Elected eight directors with votes ranging from 24.5M to 46.6M in favor; broker non-votes 1.6M.","Ratified KPMG as auditor for FY2022 with 47.2M for, 1.1M against.","Advisory say-on-pay approved with 43.2M for, 3.5M against, 74.7K abstain."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":1614797733.632,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":"2022-03-25T23:59:59+00:00|394220"}